FMRI of Cholinergic Mechanisms in Schizophrenia
Information source: VA Eastern Colorado Health Care System
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Schizophrenia
Phase: N/A
Status: Not yet recruiting
Sponsored by: VA Eastern Colorado Health Care System
Summary
This study will examine brain responses during sensory processing in patients with
schizophrenia. It will examine the hypothesis that patients treated with clozapine will
show decreased responses during sensory processing as compared to patients treated with
risperidone.
Clinical Details
Official title: FMRI of Cholinergic Mechanisms in Schizophrenia
Study design: Observational Model: Cohort, Time Perspective: Cross-Sectional
Primary outcome: BOLD FMRI response in hippocampus
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Diagnosis of schizophrenia
- treatment with clozapine or risperidone
Exclusion Criteria:
- Metal in body including pacemaker, aneurism clip, weight over 300 lbs
Locations and Contacts
Dept. of Veterans Affairs Medical Center, Denver, Colorado 80220, United States; Not yet recruiting JASON TREGELLAS, Ph.D., Phone: 303-315-1086, Email: Jason.Tregellas@uchsc.edu
University of Colorado Denver Medical School, Denver, Colorado 80262, United States; Not yet recruiting JASON TREGELLAS, Ph.D., Phone: 303-315-1086, Email: Jason.Tregellas@uchsc.edu
Additional Information
Starting date: May 2010
Last updated: July 25, 2012
|